Screener
Climb Bio, Inc. CLYM Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Climb Bio, Inc.’s reported figures.
The source filing: Climb Bio, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 7:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210357
FAQ
- What is Climb Bio, Inc.'s invested capital?
- Climb Bio, Inc. (CLYM) reported invested capital of $140.21M in Q1 2026.
- How has Climb Bio, Inc.'s invested capital changed year-over-year?
- Climb Bio, Inc.'s invested capital decreased by 14.9% year-over-year, from $164.84M to $140.21M.
- What is the long-term trend for Climb Bio, Inc.'s invested capital?
- Over 4 years (2021 to 2025), Climb Bio, Inc.'s invested capital has grown at a 0.8% compound annual growth rate (CAGR), from $121.18M to $125.33M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Climb Bio, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude